Continental Properties
2
188M
1
0.50
- Areas of investment
Summary
The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the Menomonee Falls.
The high activity for fund was in 2015. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of more than 100 millions dollars.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Continental Properties, startups are often financed by Walgreens, Rupert Murdoch, DFJ. The meaningful sponsors for the fund in investment in the same round are The Lawrence J. Ellison Revocable Trust, Tako Ventures, Raymond Bingham. In the next rounds fund is usually obtained by Walgreens, Puget Sound Venture Club, Fortress Investment Group.
Among the most popular portfolio startups of the fund, we may highlight Theranos. Among the most successful fund investment fields, there are Health Care, Consumer. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Follow on index
- 0.50
- Investments by industry
- Health Care (2)
- Monitoring Equipment (2)
- Consumer (2)
- Biotechnology (2)
- Health Diagnostics (2)
- Investments by region
-
- United States (2)
- Peak activity year
- 2015
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 8B
- Group Appearance index
- 1.00
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Theranos | 17 Nov 2006 | Monitoring Equipment, Biotechnology, Consumer, Health Care, Health Diagnostics | Late Stage Venture | 28M | United States, California, Palo Alto |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.